Dementia Today.net

Site updated at Wednesday, 22 June 2016

Living with Dementia

Neurotrophic Factor

Design of micro and nanoparticles to improve treatments for Alzheimers and Parkinsons

Enara Herran, a researcher at the UPV/EHU’s Department of Pharmacy and Pharmaceutical Technology, is working to improve the way Alzheimer’s and Parkinson’s treatments are administered. And it is a fact that, as Herran herself stressed, “both diseases are becoming more and more common in our society”.

Both disorders affect the neurones: their structure and… Design of micro and nanoparticles to improve treatments for Alzheimers and Parkinsons   



Enid and George - Life with dementia

mild traumatic brain injury1 - 1215-lipoxygenase1 - mitochondrial function1 - amyloid-β1 - dementia risk4 - amyloid proteins1 - sinus issues1 - solanezumab1 - protein alpha-synuclein1 - risk of stroke1 - memantine1 - general anesthesia1 - beta amyloid protein1 - disease progression1 - alzheimer's and parkinson's diseases1 - dementia cases2 - psychiatric status rating scales1 - alzheimer's disease risk3 - penn medicine1 - initiative1 - lewy body parkinson's disease1 - selective serotonin reuptake inhibitor2 - alzheimer’s vaccine1 - familial alzheimer's disease2 - alzheimers patients3 - amylin deposition1 - hiv dementia1 - amnesia1 - harvard medical school1 - glucose hypometabolism1 -